Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 85 cancer therapy PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
cancer therapy PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
We have 85 cancer therapy PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
PhD saved successfully
Nanoparticle synthesis and application in magnetic field hyperthermia for cancer therapy
Research Group:
Chemistry and Biosciences
Magnetic field hyperthermia (MFH) is currently undergoing clinical trials for use in humans. The research to date has shown the effectiveness of the approach in cells and animal models and the initial results from human trials are promising. Read more
Last chance to apply
Cardiovascular effects of combination therapy with VEGF inhibitors and immune checkpoint inhibitors in cancer treatment
The success in cancer therapy observed in the past two decades is tightly associated with the introduction of new therapeutic strategies, which include combination therapies. Read more
Role of RNA-DNA hybrids and transcription-replication conflicts in colorectal cancer
Replication stress, or replication-associated DNA damage, occurs frequently in cancer. There is a growing interest in targeting oncogene-induced replication stress for cancer therapy. Read more
Cancer: Understanding the immunosuppressive role of fibroblast and macrophages in Breast cancer
Oncolytic viruses (OVs) preferentially infect and kill cancer cells, and their clinical efficacy has been demonstrated against a number of different cancers. The most clinically advanced OV is a genetically engineered herpes simplex virus (T-VEC) which expresses GMCSF to aid the development of anti-tumour immune responses; T-VEC is approved for the treatment of metastatic melanoma. Read more
Investigating the Mechanobiology of Cancer
Cancer is the second-leading cause for death globally and there is a high demand for novel approaches to understand and treat cancer. Read more
Cancer: Epigenetic therapy using microbubble-mediated drug delivery for colorectal cancer
The project is an interdisciplinary, pre-clinical study that aims to investigate the response of human tumour cells to treatment with epigenetic inhibitors (including DNA methyltransferase inhibitors, HDAC inhibitors and/or vitamin C), as a potential combination therapy for colorectal cancer (CRC). Read more
Mechanisms of Cancer Stem Cell Survival, Metastasis Formation and Immune Evasion in Cancer
Recent research suggests that cancer cells within a tumour represent a highly heterogeneous cell population. In particular many tumours contain small percentage of cells that share several characteristics with stem cells. Read more
Mechanisms of interactions between isothiocyanates and diterpenoids in cancer chemoprevention. (BAOY_U23FMHCPRT )
High consumption of cruciferous vegetables can reduce the risk of cancer. This protection is attributed to high level of glucosinolates and their breakdown products, isothiocyanates (ITCs), in cruciferous vegetables. Read more
Last chance to apply
Understanding fibroblast phenotype and immunological function in cancer: targeting strategies to improve immunotherapy
The Experimental Pathology Group offers a PhD studentship in cancer biology, leading to a PhD degree from the University of Southampton. Read more
Flexible synthesis of cancer survival data incorporating electronic health records
The project is suitable for candidates with strong statistical background, ideally with MSc in Medical Statistics, Biostatistics or Statistics. Read more
Advanced 3D models for Cancer Research
Radiotherapy and many chemotherapies kill cells by damaging DNA. The efficiency of these DNA damaging agents differs between tumour types and individual patients. Read more
Development of a multi-gene detection model for Chinese Luminal-type early breast cancer and its clinical translational study on the predictive value of breast cancer recurrence risk
Supervisors. Principal supervisor. Professor/Dr Jia Meng (XJTLU). Co-supervisor. Professor/Dr Xinghong Luo (JITRI). Co-supervisor. Read more
Developing new treatment combinations to target dormant cancer cells in myeloma
Multiple myeloma is the second most common blood cancer and remains essentially incurable. Chemotherapy is effective at reducing tumour and extends survival, but it never fully eradicates disease, so patients face inevitable relapse. Read more